Issued Patents 2022
Showing 1–9 of 9 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11530420 | Nucleic acid construct | Martin Pulé | 2022-12-20 |
| 11479614 | Methods for treating cancer or modulating T cells or NK cells in a subject with cancer by administering cells comprising chimeric cytokine receptors | Martin Pulé, Matteo Righi, James Sillibourne, Shimobi Onuoha, Simon Thomas | 2022-10-25 |
| 11479613 | Methods for treating cancer or modulating T cells or NK cells in a subject by administering cells comprising chimeric transmembrane proteins | Martin Pulé, Matteo Righi, James Sillibourne, Shimobi Onuoha, Simon Thomas | 2022-10-25 |
| 11466070 | Signalling system | Martin Pulé, Simon Thomas, Shimobi Onuoha, Maria Stavrou | 2022-10-11 |
| 11440961 | Anti TRBC1 antigen binding domains | Simon Thomas, Shimobi Onuoha, Ram Jha, Wen Chean Lim | 2022-09-13 |
| 11434293 | Anti TRBC1 antigen binding domains | Simon Thomas, Shimobi Onuoha, Ram Jha, Wen Chean Lim | 2022-09-06 |
| 11365262 | Cell | Martin Pulé, Matteo Righi, James Sillibourne | 2022-06-21 |
| 11345734 | Chimeric T cell | Martin Pulé, Simon Thomas, Khai Kong | 2022-05-31 |
| 11242377 | Chimeric receptor with ligand binding exodomain and cytokine and T cell signalling endodomains | Martin Pulé, Matteo Righi | 2022-02-08 |